Checkmate Pharmaceuticals, Inc.: rnd_expense

Value{"amount": 11648000, "concept": "us-gaap:ResearchAndDevelopmentExpense", "currency": "USD"}
Period2022-01-01 – 2022-03-31
Statuscurrent
EntityCheckmate Pharmaceuticals, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001193125-22-148774 · Open the official SEC filing →
Retrieved: 2026-08-19T17:00:28.648796+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001651431/rnd-expense/2022-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/6d2ba182-ebf9-4f30-a384-e8241847b28f

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies